✦ LIBER ✦

4054 POSTER Placebo-controlled, randomized, phase II study of radium-223 in metastatic hormone refractory prostate cancer (HRPC)

✍ Scribed by Nilsson, S.; Franzén, L.; Tyrrell, C.; Blom, R.; Tennvall, J.; Lennernäs, B.; Johannessen, D.C.; Sokal, M.; Parker, C.; Bruland, O.S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bone-targeted radium-223 in symptomatic,

✍ Sten Nilsson; Lars Franzén; Christopher Parker; Christopher Tyrrell; René Blom; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 202 KB

Phase II study of topotecan in metastati

✍ Gary R. Hudes; Richard Kosierowski; Richard Greenberg; Harry E. Ramsey; Stephen 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 562 KB

Phase 3, randomized, placebo-controlled

✍ Joel B. Nelson; Karim Fizazi; Kurt Miller; Celestia Higano; Judd W. Moul; Hideyu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 846 KB

Phase I-II study of the somatostatin ana

✍ Maulard, C; Richaud, P; Droz, JP; Jessueld, D; Thomas, F; Housset, M 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 178 KB

211 POSTER Results of a phase II study o

✍ R. DeJager; L. Roman; N. Lopatkin; P. Karlov; H.B. Breitz; R. Earhart 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

MP-22.08: Phase II study of two doses of

✍ O. Blanco; D. Castellano; A. Rodrı́guez-Antolı́n; L. Paz-Ares; O. Leiva 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB